[{"address1": "1185 Avenue of the Americas", "address2": "3rd Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "973 242 0005", "website": "https://www.synaptogen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Synaptogenix, Inc. operates as a biopharmaceutical company. The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing. The company was incorporated in 2012 and is headquartered in New York, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan J. Tuchman M.D., MBA(FAAN)", "age": 77, "title": "CEO & Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 278234, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel L. Alkon M.D.", "age": 82, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1942, "fiscalYear": 2024, "totalPay": 350000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Weinstein", "age": 64, "title": "CFO, Executive VP, Treasurer & Secretary", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 565876, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.22, "open": 2.3225, "dayLow": 2.16, "dayHigh": 2.3978, "regularMarketPreviousClose": 2.22, "regularMarketOpen": 2.3225, "regularMarketDayLow": 2.16, "regularMarketDayHigh": 2.3978, "payoutRatio": 0.0, "beta": 1.293, "forwardPE": -0.25292742, "volume": 13482, "regularMarketVolume": 13482, "averageVolume": 8048, "averageVolume10days": 7410, "averageDailyVolume10Day": 7410, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3002011, "fiftyTwoWeekLow": 1.84, "fiftyTwoWeekHigh": 5.05, "fiftyDayAverage": 2.44784, "twoHundredDayAverage": 2.98697, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -13658002, "profitMargins": 0.0, "floatShares": 1380698, "sharesOutstanding": 1389820, "sharesShort": 4892, "sharesShortPriorMonth": 11978, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0034999999, "heldPercentInsiders": 0.01901, "heldPercentInstitutions": 0.03762, "shortRatio": 0.47, "shortPercentOfFloat": 0.0034999999, "impliedSharesOutstanding": 1389820, "bookValue": 4.321, "priceToBook": 0.4998843, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13558458, "trailingEps": -10.99, "forwardEps": -8.54, "lastSplitFactor": "1:25", "lastSplitDate": 1712275200, "enterpriseToEbitda": 2.007, "52WeekChange": -0.54132235, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 2.16, "recommendationKey": "none", "totalCash": 17656220, "totalCashPerShare": 12.704, "ebitda": -6805152, "totalDebt": 0, "quickRatio": 17.408, "currentRatio": 17.472, "returnOnAssets": -0.17429, "returnOnEquity": -0.78914, "freeCashflow": -7001793, "operatingCashflow": -4883988, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNPX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "messageBoardId": "finmb_268943522", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Synaptogenix, Inc.", "longName": "Synaptogenix, Inc.", "regularMarketChangePercent": -2.7027001, "regularMarketPrice": 2.16, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1747425600, "exchange": "NCM", "fiftyDayAverageChange": -0.2878399, "fiftyDayAverageChangePercent": -0.11758934, "twoHundredDayAverageChange": -0.82696986, "twoHundredDayAverageChangePercent": -0.2768591, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-07", "prevName": "Synaptogenix", "nameChangeDate": "2025-05-16", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607437800000, "regularMarketChange": -0.059999943, "regularMarketDayRange": "2.16 - 2.3978", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 8048, "fiftyTwoWeekLowChange": 0.32000005, "fiftyTwoWeekLowChangePercent": 0.17391306, "fiftyTwoWeekRange": "1.84 - 5.05", "fiftyTwoWeekHighChange": -2.89, "fiftyTwoWeekHighChangePercent": -0.57227725, "fiftyTwoWeekChangePercent": -54.132236, "epsTrailingTwelveMonths": -10.99, "epsForward": -8.54, "displayName": "Synaptogenix", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]